Progress in understanding 2-hydroxyglutaric acidurias - PubMed (original) (raw)

Review

Progress in understanding 2-hydroxyglutaric acidurias

Martijn Kranendijk et al. J Inherit Metab Dis. 2012 Jul.

Abstract

The organic acidurias D: -2-hydroxyglutaric aciduria (D-2-HGA), L-2-hydroxyglutaric aciduria (L-2-HGA), and combined D,L-2-hydroxyglutaric aciduria (D,L-2-HGA) cause neurological impairment at young age. Accumulation of D-2-hydroxyglutarate (D-2-HG) and/or L-2-hydroxyglutarate (L-2-HG) in body fluids are the biochemical hallmarks of these disorders. The current review describes the knowledge gathered on 2-hydroxyglutaric acidurias (2-HGA), since the description of the first patients in 1980. We report on the clinical, genetic, enzymatic and metabolic characterization of D-2-HGA type I, D-2-HGA type II, L-2-HGA and D,L-2-HGA, whereas for D-2-HGA type I and type II novel clinical information is presented which was derived from questionnaires.

PubMed Disclaimer

Figures

Fig. 1

Fig. 1

2-hydroxyglutaric acid with a chiral center at the 2nd carbon (*)

Fig. 2

Fig. 2

Enantiomers

d

- and

l

-2-hydroxyglutaric acid (D-2-HG and L-2-HG, systemic IUPAC names included)

Fig. 3

Fig. 3

Enzymes L-malDH and HOT are responsible for production of D-2-HG and L-2-HG from 2-KG

Fig. 4

Fig. 4

Mutations reported in D2HGDH (Misra et al ; Struys et al , ; Haliloglu et al ; Kranendijk et al ; Pervaiz et al 2011)

Fig. 5

Fig. 5

D-2-HG is formed from 2-KG via HOT. D-2-HGDH catalyzes the conversion of D-2-HG to 2-KG. D-2-HG accumulates in D-2-HGA type I patients when D-2-HGDH is impaired

Fig. 6

Fig. 6

Novel IDH2-mutant gain-of-function produces D-2-HG from 2-KG in addition to production of D-2-HG via HOT. It is hypothesized that D-2-HGDH cannot fully metabolize all of the generated D-2-HG, resulting in D-2-HG accumulation in D-2-HGA type II

Fig. 7

Fig. 7

L-2-HG is formed via the non-specific interaction of L-malDH with 2-KG using NADH. The “enzyme of metabolite repair” L-2-HGDH catalyzes the interconversion of L-2-HG to 2-KG using FAD as cofactor. L-2-HG accumulates in L-2-HGA patients when L-2-HGDH is impaired

Fig. 8

Fig. 8

Diagnostic flow chart for 2-hydroxyglutaric acidurias

References

    1. Achouri Y, Noel G, Vertommen D, Rider MH, Veiga-da-Cunha M, Van Schaftingen E. Identification of a dehydrogenase acting on D-2-hydroxyglutarate. Biochem J. 2004;381:35–42. doi: 10.1042/BJ20031933. - DOI - PMC - PubMed
    1. Aghili M, Zahedi F, Rafiee E. Hydroxyglutaric aciduria and malignant brain tumor: a case report and literature review. J Neurooncol. 2009;91:233–236. doi: 10.1007/s11060-008-9706-2. - DOI - PubMed
    1. Akaboshi S, Hogema BM, Novelletto A, et al. Mutational spectrum of the succinate semialdehyde dehydrogenase (ALDH5A1) gene and functional analysis of 27 novel disease-causing mutations in patients with SSADH deficiency. Hum Mutat. 2003;22:442–450. doi: 10.1002/humu.10288. - DOI - PubMed
    1. Amiel J, De Lonlay P, Francannet C, et al. Facial anomalies in D-2-hydroxyglutaric aciduria. Am J Med Genet. 1999;86:124–129. doi: 10.1002/(SICI)1096-8628(19990910)86:2<124::AID-AJMG7>3.0.CO;2-Q. - DOI - PubMed
    1. Baker NS, Sarnat HB, Jack RM, Patterson K, Shaw DW, Herndon SP. D-2-hydroxyglutaric aciduria: hypotonia, cortical blindness, seizures, cardiomyopathy, and cylindrical spirals in skeletal muscle. J Child Neurol. 1997;12:31–36. doi: 10.1177/088307389701200105. - DOI - PubMed

Publication types

MeSH terms

Supplementary concepts

LinkOut - more resources